Propel Bio Management, LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001969764
Type: FundHoldings: 18Value: $86.1MLatest: 2025Q1

Propel Bio Management, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 18 holdings worth $0.1 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
18
Total Value
86073350
Accession Number
0000898432-25-000357
Form Type
13F-HR
Manager Name
Propel-Bio-Management
Data Enrichment
78% identified
14 identified4 unidentified

Holdings

18 positions • $86.1M total value
Manager:
Search and click to pin securities to the top
PLAINS GP HOLDINGS LP
Shares:1.3M
Value:$27.2M
% of Portfolio:31.6% ($27.2M/$86.1M)
MADRIGAL PHARMACEUTICALS, INC.
Shares:30.0K
Value:$9.9M
% of Portfolio:11.6% ($9.9M/$86.1M)
Akero Therapeutics, Inc.
Shares:228.9K
Value:$9.3M
% of Portfolio:10.8% ($9.3M/$86.1M)
Phathom Pharmaceuticals, Inc.
Shares:1.1M
Value:$7.1M
% of Portfolio:8.3% ($7.1M/$86.1M)
ACHIEVE LIFE SCIENCES, INC.
Shares:2.5M
Value:$6.5M
% of Portfolio:7.6% ($6.5M/$86.1M)
Applied Therapeutics, Inc.
Shares:11.3M
Value:$5.5M
% of Portfolio:6.4% ($5.5M/$86.1M)
Avidity Biosciences, Inc.
Shares:178.5K
Value:$5.3M
% of Portfolio:6.1% ($5.3M/$86.1M)
ABEONA THERAPEUTICS INC.
Shares:624.0K
Value:$3.0M
% of Portfolio:3.5% ($3.0M/$86.1M)
TScan Therapeutics, Inc.
Shares:2.1M
Value:$2.9M
% of Portfolio:3.3% ($2.9M/$86.1M)
DELCATH SYSTEMS, INC.
Shares:177.6K
Value:$2.3M
% of Portfolio:2.6% ($2.3M/$86.1M)
Syndax Pharmaceuticals Inc
Shares:183.3K
Value:$2.3M
% of Portfolio:2.6% ($2.3M/$86.1M)
488445206
Shares:179.9K
Value:$1.3M
% of Portfolio:1.6% ($1.3M/$86.1M)
Milestone Pharmaceuticals Inc.
Shares:1.5M
Value:$1.2M
% of Portfolio:1.3% ($1.2M/$86.1M)
F5888J116
Shares:166.4K
Value:$1.0M
% of Portfolio:1.2% ($1.0M/$86.1M)
Compass Therapeutics, Inc.
Shares:228.3K
Value:$433.8K
% of Portfolio:0.5% ($433.8K/$86.1M)
Athira Pharma, Inc.
Shares:1.5M
Value:$425.3K
% of Portfolio:0.5% ($425.3K/$86.1M)
28249U204
Shares:146.4K
Value:$423.0K
% of Portfolio:0.5% ($423.0K/$86.1M)
169CVR016
Shares:79.4K
Value:$38.5K
% of Portfolio:0.0% ($38.5K/$86.1M)